1635.4000 19.80 (1.23%)
NSE Jun 11, 2025 15:31 PM
Volume: 996.3K
 

1635.40
1.23%
KRChoksey
Glenmark Pharma’s revenue was largely in-line with our estimates due to strong growth in India and Europe. However, EBITDA missed our estimates due to higher-than-expected employee expenses and other expenses.
Glenmark Pharmaceuticals Ltd. has gained 16.96% in the last 1 Month
More from Glenmark Pharmaceuticals Ltd.
Recommended